matrix metalloproteinase 3 modulators (IL Dong Pharmaceutical)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namematrix metalloproteinase 3 modulators (IL Dong Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase 3 modulators
TargetsMatrix metalloproteinase 3
Therapy Area/IndicationsArthritisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIldong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIldong Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsArthritisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A